- About
- Strategic Plan
- Structure
- Governance
- Scientific divisions
- ACRF Cancer Biology and Stem Cells
- ACRF Chemical Biology
- Advanced Technology and Biology
- Bioinformatics
- Blood Cells and Blood Cancer
- Clinical Translation
- Epigenetics and Development
- Immunology
- Infectious Diseases and Immune Defence
- Inflammation
- Personalised Oncology
- Population Health and Immunity
- Structural Biology
- Ubiquitin Signalling
- Laboratory operations
- Funding
- Annual reports
- Human research ethics
- Scientific integrity
- Institute life
- Career opportunities
- Business Development
- Collaborators
- Suppliers
- Publications repository
- Awards
- Discoveries
- Centenary 2015
- History
- Contact us
- Research
- Diseases
- Cancer
- Development and ageing
- Immune health and infection
- Research fields
- Research technologies
- Research centres
- People
- Alistair Brown
- Anne-Laure Puaux
- Assoc Prof Joanna Groom
- Associate Profesor Ian Majewski
- Associate Professor Aaron Jex
- Associate Professor Andrew Webb
- Associate Professor Chris Tonkin
- Associate Professor Diana Hansen
- Associate Professor Edwin Hawkins
- Associate Professor Ethan Goddard-Borger
- Associate Professor Gemma Kelly
- Associate Professor Grant Dewson
- Associate Professor Isabelle Lucet
- Associate Professor James Vince
- Associate Professor Jason Tye-Din
- Associate Professor Jeff Babon
- Associate Professor Joan Heath
- Associate Professor John Wentworth
- Associate Professor Justin Boddey
- Associate Professor Kate Sutherland
- Associate Professor Kelly Rogers
- Associate Professor Marie-Liesse Asselin-Labat
- Associate Professor Melissa Call
- Associate Professor Misty Jenkins
- Associate Professor Nawaf Yassi
- Associate Professor Oliver Sieber
- Associate Professor Rachel Wong
- Associate Professor Rhys Allan
- Associate Professor Rosie Watson
- Associate Professor Ruth Kluck
- Associate Professor Shalin Naik
- Associate Professor Sumitra Ananda
- Associate Professor Tim Thomas
- Associate Professor Tracy Putoczki
- Chela Niall
- Deborah Carr
- Dr Alisa Glukhova
- Dr Anna Coussens
- Dr Ashley Ng
- Dr Belinda Phipson
- Dr Ben Tran
- Dr Bernhard Lechtenberg
- Dr Brad Sleebs
- Dr Drew Berry
- Dr Gwo Yaw Ho
- Dr Hamish King
- Dr Hui-Li Wong
- Dr Jacqui Gulbis
- Dr Jim Whittle
- Dr Lucy Gately
- Dr Margaret Lee
- Dr Mary Ann Anderson
- Dr Maryam Rashidi
- Dr Matthew Call
- Dr Nadia Davidson
- Dr Nadia Kershaw
- Dr Philippe Bouillet
- Dr Rebecca Feltham
- Dr Rory Bowden
- Dr Samir Taoudi
- Dr Sarah Best
- Dr Saskia Freytag
- Dr Shabih Shakeel
- Dr Sheau Wen Lok
- Dr Stephin Vervoort
- Dr Yunshun Chen
- Guillaume Lessene
- Helene Martin
- Joh Kirby
- Kaye Wycherley
- Keely Bumsted O'Brien
- Mr Simon Monard
- Mr Steve Droste
- Ms Carolyn MacDonald
- Professor Alan Cowman
- Professor Andreas Strasser
- Professor Andrew Roberts
- Professor Anne Voss
- Professor Clare Scott
- Professor Daniel Gray
- Professor David Huang
- Professor David Komander
- Professor David Vaux
- Professor Doug Hilton
- Professor Geoff Lindeman
- Professor Gordon Smyth
- Professor Ian Wicks
- Professor Ivo Mueller
- Professor James McCarthy
- Professor James Murphy
- Professor Jane Visvader
- Professor Jeanne Tie
- Professor Jerry Adams
- Professor John Silke
- Professor Ken Shortman
- Professor Leanne Robinson
- Professor Leonard C Harrison
- Professor Lynn Corcoran
- Professor Marnie Blewitt
- Professor Matthew Ritchie
- Professor Melanie Bahlo
- Professor Melissa Davis
- Professor Mike Lawrence
- Professor Nicos Nicola
- Professor Peter Colman
- Professor Peter Czabotar
- Professor Peter Gibbs
- Professor Phil Hodgkin
- Professor Sandra Nicholson
- Professor Sant-Rayn Pasricha
- Professor Seth Masters
- Professor Stephen Nutt
- Professor Suzanne Cory
- Professor Terry Speed
- Professor Tony Papenfuss
- Professor Wai-Hong Tham
- Professor Warren Alexander
- Diseases
- Education
- PhD
- Honours
- Masters
- Clinician-scientist training
- Undergraduate
- Student research projects
- A multi-pronged approach to targeting myeloproliferative neoplasms
- A new paradigm of machine learning-based structural variant detection
- A whole lot of junk or a treasure trove of discovery?
- Advanced imaging interrogation of pathogen induced NETosis
- Analysing the metabolic interactions in brain cancer
- Atopic dermatitis causes and treatments
- Boosting the efficacy of immunotherapy in lung cancer
- Building a cell history recorder using synthetic biology for longitudinal patient monitoring
- Characterisation of malaria parasite proteins exported into infected liver cells
- Deciphering the heterogeneity of the tissue microenvironment by multiplexed 3D imaging
- Defining the mechanisms of thymic involution and regeneration
- Delineating the molecular and cellular origins of liver cancer to identify therapeutic targets
- Developing computational methods for spatial transcriptomics data
- Developing drugs to block malaria transmission
- Developing models for prevention of hereditary ovarian cancer
- Developing statistical frameworks for analysing next generation sequencing data
- Development and mechanism of action of novel antimalarials
- Development of novel RNA sequencing protocols for gene expression analysis
- Discoveries in red blood cell production and function
- Discovering epigenetic silencing mechanisms in female stem cells
- Discovery and targeting of novel regulators of transcription
- Dissecting host cell invasion by the diarrhoeal pathogen Cryptosporidium
- Dissecting mechanisms of cytokine signalling
- Doublecortin-like kinases, drug targets in cancer and neurological disorders
- Epigenetic biomarkers of tuberculosis infection
- Epigenetics – genome wide multiplexed single-cell CUT&Tag assay development
- Exploiting cell death pathways in regulatory T cells for cancer immunotherapy
- Exploiting the cell death pathway to fight Schistosomiasis
- Finding treatments for chromatin disorders of intellectual disability
- Functional epigenomics in human B cells
- How do nutrition interventions and interruption of malaria infection influence development of immunity in sub-Saharan African children?
- Human lung protective immunity to tuberculosis
- Improving therapy in glioblastoma multiforme by activating complimentary programmed cell death pathways
- Innovating novel diagnostic tools for infectious disease control
- Integrative analysis of single cell RNAseq and ATAC-seq data
- Interaction with Toxoplasma parasites and the brain
- Interactions between tumour cells and their microenvironment in non-small cell lung cancer
- Investigation of a novel cell death protein
- Malaria: going bananas for sex
- Mapping spatial variation in gene and transcript expression across tissues
- Mechanisms of Wnt secretion and transport
- Multi-modal computational investigation of single-cell communication in metastatic cancer
- Nanoparticle delivery of antibody mRNA into cells to treat liver diseases
- Naturally acquired immune response to malaria parasites
- Organoid-based discovery of new drug combinations for bowel cancer
- Organoid-based precision medicine approaches for oral cancer
- Removal of tissue contaminations from RNA-seq data
- Reversing antimalarial resistance in human malaria parasites
- Role of glycosylation in malaria parasite infection of liver cells, red blood cells and mosquitoes
- Screening for novel genetic causes of primary immunodeficiency
- Single-cell ATAC CRISPR screening – Illuminate chromatin accessibility changes in genome wide CRISPR screens
- Spatial single-cell CRISPR screening – All in one screen: Where? Who? What?
- Statistical analysis of single-cell multi-omics data
- Structural and functional analysis of epigenetic multi-protein complexes in genome regulation
- Structural basing for Wnt acylation
- Structure, dynamics and impact of extra-chromosomal DNA in cancer
- Targeted deletion of disease-causing T cells
- Targeting cell death pathways in tissue Tregs to treat inflammatory diseases
- The cellular and molecular calculation of life and death in lymphocyte regulation
- The role of hypoxia in cell death and inflammation
- The role of ribosylation in co-ordinating cell death and inflammation
- Understanding Plasmodium falciparum invasion of red blood cells
- Understanding cellular-cross talk within a tumour microenvironment
- Understanding the genetics of neutrophil maturation
- Understanding the roles of E3 ubiquitin ligases in health and disease
- Unveiling the heterogeneity of small cell lung cancer
- Using combination immunotherapy to tackle heterogeneous brain tumours
- Using intravital microscopy for immunotherapy against brain tumours
- Using nanobodies to understand malaria invasion and transmission
- Using structural biology to understand programmed cell death
- Validation and application of serological markers of previous exposure to malaria
- School resources
- Frequently asked questions
- Student profiles
- Abebe Fola
- Andrew Baldi
- Anna Gabrielyan
- Ashley Weir
- Bridget Dorizzi
- Casey Ah-Cann
- Catia Pierotti
- Emma Nolan
- Huon Wong
- Jasmine Rou
- Jing Deng
- Joy Liu
- Kaiseal Sarson-Lawrence
- Komal Patel
- Krishneel Prasa
- Lilly Backshell
- Malvika Kharbanda
- Megan Kent
- Naomi Jones
- Pailene Lim
- Rebecca Delconte
- Roberto Bonelli
- Rune Larsen
- Runyu Mao
- Sarah Garner
- Simona Seizova
- Sophie Collard
- Wayne Cawthorne
- Wil Lehmann
- Yanxiang Meng
- Zhong Yan Gan
- Miles Horton
- Alexandra Gurzau
- Student achievements
- Student association
- Learning Hub
- News
- Donate
- Online donation
- Ways to support
- Support outcomes
- Supporter stories
- Rotarians against breast cancer
- A partnership to improve treatments for cancer patients
- 20 years of cancer research support from the Helpman family
- A generous gift from a cancer survivor
- A generous vision for impactful medical research
- A gift to support excellence in Australian medical research
- An enduring friendship
- Anonymous donor helps bridge the 'valley of death'
- Philanthropy through the power of sisterhood
- Renewed support for HIV eradication project
- Searching for solutions to muscular dystrophy
- Supporting research into better treatments for colon cancer
- Taking a single cell focus with the DROP-seq
- Donors
- WEHI.TV
A tribute to Professor Donald Metcalf
AC BSc(Med) MD Syd FRACP HonDSc SydHonMD Oslo HonFRCPath London FRCPA FAA FRS
(26 February 1929 to 15 December 2014)
Once more unto the breach, dear friends, once more,
Or close the wall up with our English dead!
In peace there’s nothing so becomes a man
As modest stillness and humility,
But when the blast of war blows in our ears,
Then imitate the action of the tiger:
Stiffen the sinews, summon up the blood.
King Henry, Henry V (Shakespeare)[1]
Donald Metcalf – Don to most everyone with whom he worked – was a Colossus of science who, working at the Walter and Eliza Hall Institute and supported by the Cancer Council of Victoria from 1954 to 2014, stood astride the world of haematology (the study of blood cells) for 60 years.
The achievements of Don, the scientist, are legion. Don introduced cancer research to the Walter and Eliza Hall Institute at a time when its Director, the Nobel Prize winner Sir Frank MacFarlane Burnet, viewed cancer as an “inevitable disease”, with “anyone who wants to do cancer research, either a fool or a rogue”.
Don politely ignored him.
Studying leukemia in 1964, Don and Ray Bradley, from The University Of Melbourne, discovered it was possible to grow bone marrow cells in plates of partly set agar jelly. Don’s genius lay not in this breakthrough, but in the realisation that it could be used to understand the cellular basis of blood cell production and to discover the hormones, which he named colony-stimulating factors, that regulate blood cell production in the body.
Don worked single-mindedly on this theme for the next 50 years. He characterised blood stem cells and their daughters cells, which are committed to producing the multiple types of white blood cells that fight infection and prevent bleeding. In doing so he made the blood cell system the ‘poster child’ of medical research and shone a light into the darkness for those who followed him to work on understanding other tissues such as the breast, skin and colon.
Don also understood his limitations. Although he was comfortable with cells, he was wary of molecules such as DNA and protein. Nevertheless, Don knew he needed collaborators who would take him out his comfort zone and help him fulfill his ambition of delivering health benefits from his discoveries and so he assembled a team of researchers who worked with him for 40 years. Don’s ability to identify a glimmer of talent in younger researchers and mold them into a cohesive, loyal and vibrant team that consistently came up with ground-breaking discoveries, was remarkable. Decades ahead of its time, his model of collaborative, multidisciplinary science shaped the culture of the Walter and Eliza Hall Institute and is now seen as almost mandatory if big problems are to be tackled and significant breakthroughs are to be made in medical science.
After two decades of dogged progress, Don and his team succeeded in the Herculean task of isolating four of the blood CSFs, which were present in tiny quantities in the body. Despite Don’s profound fundamental discoveries, which shaped basic understanding of how blood cells are made and work, he always recognised and espoused the responsibility of medical research to help those suffering illness and disease. Isolation and cloning the CSFs paved the way for their mass-production and clinical testing. Don found that injection of the hormones into animals resulted in a rapid increase in the number of blood cells responsible for battling infection and he surmised that they might be used to help cancer patients overcome one of the major side effects of chemotherapy: a loss of white cells and susceptibility to life-threatening infection. Don’s hunch about clinical use was proven true – over the past 20 years, more than 20 million cancer patients, including Spanish tenor Jose Carreras, have been treated with CSFs and, as a result, have been given the best possible chance of beating their cancer. CSFs are now standard treatment and every year the number of people alive because of Don’s work grows. There can be no greater legacy for a medical researcher.
Remarkable though his scientific achievements were – more than 750 scientific papers, 21 patents and receipt of almost every major international prize in medical research, they give only a skeletal outline of the man.
Don was practical – he eschewed the modern trend of senior researchers to move permanently from the laboratory to oversee a large team from the safety of an office. He was a man of scientific action. Many a young researcher was left with ears ringing after a spray from Don that would make John Kennedy senior’s 1971 half-time grand final address to his Hawthorn players (“At least DO SOMETHING! DO! Don't think, don't hope, do!”)seem like polite encouragement.
Don was hard working. He led from the front and expected his team to follow. From the day he entered medical research, until he was diagnosed with cancer four months ago, he would begin work early, between 7.00 am and 7.30 am either doing experiments or writing scientific papers solidly until 5.30 pm; his only compromise being a lunchtime or mid afternoon finish on Saturday. Upon a new recruit starting in his unit, it was mandatory for them to meet with Don who, at least until the mid 1990s, would be smoking a cigar, and would lull you with a question like “have you had a good holiday” - inviting a response like, “yes thank you Professor Metcalf, I have had a lovely two weeks camping at Wilson’s Promontory” - which was then followed by “excellent, that’s the last holiday you will have for three years, get to work”. And it was the last holiday you took, not because Don would stop you taking leave, but because his hard work was infectious and the lab would become your world.
Don was loyal. He was loyal to the Walter and Eliza Hall Institute – working there almost continuously for 60 years from 1954 to 2014, despite lucrative offers from all over the world. Don enjoyed the tyranny of distance, which he believed made it easier for Australian scientists to pursue highly original research, away from the latest trends and fads. Don was steadfastly loyal to the four directors, under whom he worked and sometimes disagreed. His attitude approached a US-style respect for the office of the President. Although deeply suspicious and somewhat intolerant of people he called “prancers” or “strutters” once you had proven yourself to be practical, thoughtful, reliable, hardworking and collaborative, you were ‘in’. Being ‘in’ meant a draft of a scientific paper would come back from Don’s office with more red ink than black type. It meant you could be mercilessly interrogated about your science during a seminar or excoriated over some minor antisocial laboratory behavior. Being ‘in’ meant you would be defended to the hilt in front of visitors or other groups. You became part of the team. There was no greater honour.
Don was human - he was no uncaring science machine. He loved banter over afternoon tea, often laughing until tears streamed down his face, at some silly anecdote or remark. He loved an annual week on the Sunshine coast with his wife, which included body surfing, into his late 70s, on waves of any size. He enjoyed a meal and a glass of wine with friends. And more than anything he loved his family - his wife of more than 60 years, Josephine (Jo), his four daughters and his six grandchildren, meant everything to him. He knew, and often publicly acknowledged, that without them he would have achieved little of note.
Other than a bad back, which was exacerbated by endless hours, days, weeks, months and years bent at the microscope, Don enjoyed relative good health until August this year. Feeling under the weather, he went on leave hoping some time away from the laboratory would rejuvenate him. He returned feeling worse and was quickly diagnosed with metastatic pancreatic cancer. Knowing the likelihood of cure was not high, his priorities were to undertake some treatment to give him a few extra weeks or months so as to avoid letting down his collaborators and, most importantly, to spend as much time as possible with his beloved Jo and his daughters - but how to do both of these things? The solution for the scientist and family man until the end – have his microscope moved into his home. Don performed his last experiment in October and died surrounded by his family on 15 December 2014. He would have wanted it no other way.
Professor Douglas Hilton,
Director of Walter and Eliza Hall Institute Of Medical Research
Professor Warren Alexander and Professor Nicos Nicola
Heads of Division of Cancer and Haematology, Walter and Eliza Hall Institute of Medical Research
[1] This was one of Don’s favorite passages, the other being Tennyson’s Charge of the Light Brigade. Don’s autobiography was entitled “Summon up the Blood: In dogged pursuit of the blood cell regulators” (AlphaMed Press, Dayton, Ohio, USA, 2000. ISBN 1-880854-28-7).